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THE MEDICAL IMMORTALITY of being commemorated with an eponym has been achieved by physicians and pathologists who discover or describe some ailment, such as Addison's disease and von Recklinghausen's disease, and by surgeons who have invented operative procedures and instruments. For T. Duckett Jones, an eponymic title was attained with a different achievement: He created a set of rules for making an intellectual decision.
It was not the first time that a medical eponym had been given to a decision rule. Robert Koch is well known not only for having found the tubercule bacillus, but also for proposing a strategy of etiologic inferential reasoning, borrowed from Henle, that we now call Koch's postulates..' The work of Duckett Jones was unique in providing a formal rule for diagnostic designation rather than for etiologic inference. Realizing that many clinical ailments could not be identified with a specific histologic pattern or with other forms of pathognomonic evidence, Jones in 1944 published a set of criteria2 for diagnosing acute rheumatic fever. He is known as the source of the first medical eponym for a set of rules for making a diagnostic decision: the Jones criteria.
Like all scientific innovations, the criteria were not perfect; they have been improved during two revisions.3 4 Their basic ideas and contents, however, are intact; and the criteria have had a profound, fundamental impact in clinical science. Many people believe that our major progress of the past few decades in controlling rheumatic heart disease has been primarily a result of the immunologic antibody techniques that allowed the group A streptococcus to be confirmed as the cause and the antibiotics that allowed streptococcal infections to be eradicated or prevented. Nevertheless, just as the control of poliomyelitis required the more basic development of tissue culture techniques, the control of rheumatic fever also required a more basic accomplishment.
That basic accomplishment was the Jones criteria, which allowed clinicians to agree on the process of diagnosing and on how to treat rheumatic fever. This consistency in diagnostic identification of the disease has allowed us to investigate it precisely, to treat it effectively and to prevent it. By demarcating a clearly defined spectrum of disease, the Jones criteria excluded a series of minor ailments that formerly masqueraded under the rheumatic title, and thereby produced a consistent selection of clinical entities that would be diagnosed as acute rheumatic fever.5 6 verity of symptoms by separating those that are mild or moderate from those that are severe and incapacitating. We do not indicate the chronometry of symptoms by specifying their duration and sequence. Thus, if one patient has had chest pain and dyspnea for 10 years and another for 10 days, we seldom consider this distinction when we analyze their data. We also do not distinguish a patient who had chest pain for many years and who then developed dyspnea from a patient with a reversal of this sequence.
We regularly omit auxometry -the rate of growth or progression of the disease.24 Only in recent years, for example, have we begun to differentiate stable angina pectoris from crescendo angina; and in patients with cancer, our anatomic staging system fails to discriminate those with rapid growing tumors from those with slow growth, even though this distinction can be made readily from using the patient's history.24
Many other clinical phenomena could be cited to illustrate the important human events that are neglected in our current statistics, but because of time constraints, the only other one I shall note is performance status or functional capacity. Indexes of performance 
If the scales and criteria are suitably constructed, the results can be regarded as measurements regardless of whether they are cited in the kinds of dimensional numbers that so enchanted Lord Kelvin,26 or in categorical expressions. Thus, the kind of scale that is usually regarded as a measurement provides ranked dimensions, such as 0 , 1, 2, 3, . . . , 99, 100 components that are used to enter data into the criteria. Thus, we look first at the observed evidence, and then ments. In the Jones diagnostic criteria, for example, the observed evidence may consist of such things as pain and swelling or redness of a joint, and the characteristics noted in cardiac murmurs or in an ECG. The salient elements into which we convert this evidence are described in such terms as arthritis, carditis, chorea or erythema marginatum. Our next step is to decide how these salient elements will be arranged or aggregated into what might be called principal axes. Duckett Jones arranged his salient elements into two principal axes, the major and the minor axes. We then decide how these principal axes are to be converted or arranged into the particular expression that serves as the focal index. In the Jones diagnostic criteria, the focal index is an expression such as yes or no for the diagnosis of rheumatic fever. The instructions for converting the principal axes into that focal index require such things as two elements in a major axis and one element in a minor axis.
We must also engage in the process of justification for the criteria. For the type of activity I am describing, the process of justification has its counterpart in the calibration or standardization that is used for the procedures that provide dimensional data in laboratory work. The justification methods for a scale and its associated criteria can involve three different kinds of activity. One of them is used to demonstrate consistency -the results noted when different observers apply the criteria and the scale in the same situation. The second activity requires external validation, with or without external evidence. For example, a clinical diagnosis of coronary artery disease -using clinical, electrocardiographic and laboratory data -can be externally validated with roentgenographic evidence during coronary arteriography. If no external evidence can be acquired, perhaps the best way of validating a scale is through the consensual agreement of a panel of experts or other authorities. The assembled panel will use Delphi28 or other techniques to arrive at agreement on the expression, qualification and value of the criteria. In many other circumstances, a form of external validation can be obtained to show the "efficacy" of the scale. For example, a set of criteria that performs a diagnostic function can be checked for its sensitivity and specificity. A set of criteria that provides a prognostic prediction can be checked for its predictive accuracy. A set of criteria that provides classification or descriptions of quality can be checked for its impact on the associated clinical conditions in which the criteria are customarily used.
The focal index that expresses the final result of a set of criteria can be created in two main ways: as an additive score or as a Boolean cluster. An excellent example of the additive score technique is the Apgar score. When Virginia Apgar decided that she was tired of using gestalt observations to refer to the condition of a newborn baby as excellent, good, fair, and so on, she created a specific scoring system. She first identified five different components to be observed. They consisted of such things as heart rate, respiration and color. For each of these five entities, she set up a simple rating scale of 0, 1 With the removal of these barriers, clinicians can proceed with the development of a scientific scholarship of our own a scholarship that can provide a "hardening" and respectibility for the important, crucial, "soft" data of clinical medicine. We must immust establish scales and rating systems for clinical phenomena that are currently unidentified; and we must create criteria for the use of those scales. The results will lead to the development of an intellectual domain that might be called clinimetrics. We must make this domain grow and take its place as a worthy, intellectually vigorous member of the rest of the "metric" family.
Biometrics is one of the earliest members of this family. It was created in the late 19th century when Sir Francis Galton fused the methods of biology with the methods of quantification and mensuration. With time, however, the leaders of the world of biometry began to turn away from their primary concern with biology and biologic data. Biometry began to take the more theoretical and analytic issues of mathematical statistics as its prime creative challenge.29 Consequently, when other people began to look for help in their own problems of measurement, they did not find it in biometry and they eventually established their own "metric" domains. Thus, it was that psychologists, developing rating scales for anxiety and intelligence, began to create a domain called psychometrics, a domain also occupied by people who do eduational testing and evaluating of examination procedures. In the world of sociology, the need to establish rating scales for social and familial interactions led to the creation of sociometry. In economics, the need for quantitative analysis and quantitative models of the economic process led to the creation of econometrics. (One of the founders of this domain was recently awarded the Nobel Prize for his work.) Engineers, despite the dimensional data available to them, have created both an intellectual domain and a journal called Technometrics. Even in the field of the humanities, historians who have used the quantitative analysis of data to interpret historical phenomena have taken the name of Clio, the muse of history, to establish cliometrics.
As clinicians enter the "metric" family, we shall find many humanistically oriented friends and relatives awaiting us. They joined the family because they wanted to give intellectual respect and creative scholarship to their important activities. The methods and strategies our "relatives" have already developed can be quite helpful, but we shall have to make careful decisions about which techniques can be usefully transplanted and which ones we need to develop. The challenges of clinimetrics arise because we have improved our methods of precisely identifying all the data of patient care except the uniquely clinical phenomena that distinguish sick people from animals or molecules. We measure survival but not the quality of life; we report accomplishments in curing disease, but not in helping sick people by relieving symptoms, providing comfort, or enhancing functional capacity. We may then complain that the accomplishments of medical care are evaluated with inappropriate data, such as length of hospitalization, infant mortality rates, and statistics on life expectancy. The blame, however, is really ours. As clinicians and investigators, we have made very few efforts to expand the scope of the hard and objective but deliberately dehumanized data that are the main information available and encouraged for statistical analysis. If we believe that the human art of clinical medicine is worth preserving and worth analyzing, we must specify the ingredients of that art and express them as documentary evidence. The development of clinimetrics allows us to maintain and improve clinical art while advancing the state of clinical science.
For scholarly clinical investigators and for practicing physicians who want to contribute to clinical scholarship, clinimetrics offers a fundamental creative challenge and an opportunity to achieve eponymic memorials. If we recall the Apgar score for newborn children, the Bayley scale of childhood development, and the Killip classes and Norris-Peel indexes of severity in acute myocardial infarction, we can recognize the eponymic descendants of the Jones diagnostic criteria; we can see the evolutionary intellectual advances that have followed Jones's original ideas; and we can also be stimulated by how much more work remains to be done.
